J. C. Watson

发表

Undetectable Preoperative Levels of Serum CA 19-9 Correlate with Improved Survival for Patients with Resectable Pancreatic Adenocarcinoma

I. Meszoely, E. Ross, A. Berger, 2004, Annals of Surgical Oncology.

Proteomic Analyses of Pancreatic Cyst Fluids

Bhavinkumar B. Patel, J. Tokar, S. Litwin, 2009, Pancreas.

Modulation of tumor endothelial cell marker 7 expression during endothelial cell capillary morphogenesis.

N. Sheibani, J. C. Watson, Xue-qing Wang, 2005, Microvascular research.

Resection of Isolated Pelvic Recurrences after Colorectal Surgery: Long-Term Results and Predictors of Improved Clinical Outcome

E. Ross, L. Henry, E. Sigurdson, 2007, Annals of Surgical Oncology.

Resection of Isolated Pelvic Recurrences After Colorectal Surgery: Long-Term Results and Predictors of Improved Clinical Outcome

E. Ross, L. Henry, E. Sigurdson, 2006, Annals of Surgical Oncology.

Internal Mammary Lymph Nodes

J. C. Watson, J. Hoffman, 2002 .

Simultaneous Expression of Furin and Vascular Endothelial Growth Factor in Human Oral Tongue Squamous Cell Carcinoma Progression

A. Klein-Szanto, S. Litwin, D. Bassi, 2004, Clinical Cancer Research.

Defining Venous Involvement in Borderline Resectable Pancreatic Cancer

J. Tokar, P. Engstrom, I. Astsaturov, 2010, Annals of Surgical Oncology.

Hepatic artery infusional chemotherapy for colorectal liver metastases.

E. Sigurdson, A. Sasson, J. C. Watson, 2001, Cancer treatment and research.

Impact of preoperative therapy on patterns of recurrence in pancreatic cancer.

Steven J. Cohen, Joshua E. Meyer, J. C. Watson, 2014, HPB : the official journal of the International Hepato Pancreato Biliary Association.

Efficacy Endpoints of RTOG 0247: A Randomized Phase II Study of Neoadjuvant Radiation Therapy Plus Concurrent Capecitabine and Irinotecan or Capecitabine and Oxaliplatin for Patients with Locally Advanced Rectal Cancer

B. Erickson, A. Rashid, C. Willett, 2015 .

Can molecular imaging predict response to preoperative chemoradiation in patients with rectal cancer? A Fox Chase Cancer Center prospective experience.

P. Engstrom, Steven J. Cohen, E. Sigurdson, 2005, Seminars in oncology.

Somatostatin analogs: angiogenesis inhibitors with novel mechanisms of action

E. Woltering, J. C. Watson, R. Barrie, 2004, Investigational New Drugs.

RADIATION THERAPY ONCOLOGY GROUP RTOG S-0120 A RANDOMIZED PHASE I/II STUDY OF PREOPERATIVE RADIOTHERAPY WITH/WITHOUT SUGEN 5416 (NSC #696819; A TK INHIBITOR ANTI-ANGIOGENESIS COMPOUND) IN THE MANAGEMENT OF LOW TO INTERMEDIATE GRADE SOFT TISSUE SARCOMA OF THE TRUNK OR EXTREMITY

D. Ettinger, W. Kraybill, J. C. Watson, 2002 .

Intraoperative gamma detection of 125I-lanreotide in women with primary breast cancer

E. Levine, E. Woltering, T. O'Dorisio, 1996, Regulatory Peptides.

Phase II Trial of Neoadjuvant/Adjuvant Imatinib Mesylate (IM) for Advanced Primary and Metastatic/Recurrent Operable Gastrointestinal Stromal Tumor (GIST) – early results of RTOG 0132

G. Demetri, B. Eisenberg, M. Heinrich, 2011 .

Is Reporting of Recurrence Data Important in Pancreatic Cancer?

B. Eisenberg, I. Meszoely, E. Ross, 2004, Annals of Surgical Oncology.

RTOG 0247: A randomized phase II study of neoadjuvant capecitabine and irinotecan versus capecitabine and oxaliplatin with concurrent radiation therapy for locally advanced rectal cancer

A. Rashid, C. Willett, L. Kachnic, 2008 .

Dacron femoral-popliteal bypass grafts in good-risk claudicant patients.

J. C. Watson, K. Johansen, 2004, American journal of surgery.

Survival After Pancreatectomy With Major Arterial Resection and Reconstruction

Steven J. Cohen, K. Stitzenberg, J. C. Watson, 2008, Annals of Surgical Oncology.

Growing vascular endothelial cells express somatostatin subtype 2 receptors

E. Woltering, J. C. Watson, B. Gebhardt, 2001, British Journal of Cancer.

The Metastatic/Examined Lymph Node Ratio is an Important Prognostic Factor after Pancreaticoduodenectomy for Pancreatic Adenocarcinoma

E. Ross, A. Berger, J. C. Watson, 2004, The American surgeon.

Potential Prognostic Biomarkers of Pancreatic Cancer

Kelly A. Jones, Bhavinkumar B. Patel, J. Tokar, 2014, Pancreas.

Pancreatic cancer

Steven J. Cohen, N. Meropol, J. C. Watson, 2000, Current treatment options in oncology.

Challenges in the treatment of angiosarcoma: a single institution experience.

J. Gaughan, M. von Mehren, J. C. Watson, 2014, American journal of surgery.

Vascular endothelial growth factor is a marker of tumor invasion and metastasis in squamous cell carcinomas of the head and neck.

M. Herlyn, S. Litwin, E. Sauter, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Phase II and Coagulation Cascade Biomarker Study of Bevacizumab With or Without Docetaxel in Patients With Previously Treated Metastatic Pancreatic Adenocarcinoma

L. Weiner, I. Astsaturov, B. Burtness, 2011, American journal of clinical oncology.

Phase II trial of neoadjuvant/adjuvant imatinib mesylate (IM) for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumor (GIST): Early results of RTOG 0132/ACRIN 6665

G. Demetri, B. Eisenberg, M. Heinrich, 2009, Journal of surgical oncology.

Efficacy endpoints of radiation therapy group protocol 0247: a randomized, phase 2 study of neoadjuvant radiation therapy plus concurrent capecitabine and irinotecan or capecitabine and oxaliplatin for patients with locally advanced rectal cancer.

B. Erickson, A. Rashid, C. Willett, 2015, International journal of radiation oncology, biology, physics.

Radiation Therapy Oncology Group 0247: a randomized Phase II study of neoadjuvant capecitabine and irinotecan or capecitabine and oxaliplatin with concurrent radiotherapy for patients with locally advanced rectal cancer.

B. Erickson, A. Rashid, C. Willett, 2012, International journal of radiation oncology, biology, physics.

OF NEOADJUVANT CAPECITABINE AND IRINOTECAN OR CAPECITABINE AND OXALIPLATIN WITH CONCURRENT RADIOTHERAPY FOR PATIENTS WITH LOCALLYADVANCED RECTAL CANCER

B. Erickson, A. Rashid, C. Willett, 2012 .

Partial stomach-partitioning gastrojejunostomy and the success of this procedure in terms of palliation.

Tianyu Li, J. C. Watson, J. Hoffman, 2013, American journal of surgery.

A murine model of ex vivo angiogenesis using aortic disks grown in fibrin clot.

A. Berger, J. C. Watson, Xue-qing Wang, 2004, Microvascular research.

Partial stomach-partitioning gastrojejunostomy for malignant duodenal obstruction.

J. C. Watson, J. Hoffman, C. Arciero, 2006, American journal of surgery.

Perioperative tyrosine kinase inhibitors for GIST: standard ... or an idea that needs further investigation?

M. von Mehren, J. C. Watson, 2009, Oncology.

Gastrointestinal stromal tumors.

M. von Mehren, J. C. Watson, 2005, Hematology/oncology clinics of North America.

Vascular Endothelial Growth Factor Is a Marker of Tumor Invasion and Metastasis in Squamous Cell Carcinomas of the Head and Neck 1

M. Herlyn, S. Litwin, E. Sauter, 1999 .

Neoadjuvant Therapy and Biliary Decompression Lower Biliary and Pancreatic Juice Vascular Endothelial Growth Factor Levels in Patients with Periampullary Adenocarcinoma

E. Ross, A. Berger, J. C. Watson, 2004, The American surgeon.

Breast cancer increases initiation of angiogenesis without accelerating neovessel growth rate.

E. Woltering, J. C. Watson, B. Gebhardt, 1997, Surgery.

Angiogenesis and hepatic colorectal metastases.

J. C. Watson, M. Meyers, 2003, Surgical oncology clinics of North America.

Importance of timing and length of administration of angiogenesis inhibitor TNP-470 in the treatment of K12/TRb colorectal hepatic metastases in BD-IX rats.

J. Babb, E. Sigurdson, J. C. Watson, 1999, Surgery.

Significance of Common Hepatic Artery Lymph Node Metastases During Pancreaticoduodenectomy for Pancreatic Head Adenocarcinoma

F. Cordera, Tianyu Li, J. C. Watson, 2007, Annals of Surgical Oncology.

Peritoneal Cytology in Patients with Potentially Resectable Adenocarcinoma of the Pancreas

I. Meszoely, J. C. Watson, J. Hoffman, 2004, The American surgeon.

Isolation and characterization of circulating tumor cells in patients with metastatic colorectal cancer.

L. Weiner, W. J. Allard, L. Terstappen, 2006, Clinical colorectal cancer.

Chemoradiation followed by chemotherapy before resection for borderline pancreatic adenocarcinoma.

H. Cooper, K. Brown, J. C. Watson, 2008, American journal of surgery.

Intraoperative Gamma Detection Of125I-Lanreotide in Women With Primary Breast Cancer

E. Levine, E. Woltering, T. O'Dorisio, 1999, Annals of Surgical Oncology.

Surgical management of local and regional recurrent head and neck squamous cell carcinoma.

J. Ridge, J. C. Watson, 1998, Current opinion in oncology.

Outcome and Natural History of Patients with Stage IV Colorectal Cancer Receiving Chemotherapy Without Primary Tumor Resection

F. Zhu, E. Sigurdson, J. C. Watson, 2012, Annals of Surgical Oncology.

Phase II Trial of Neoadjuvant/adjuvant Imatinib Mesylate for Advanced Primary and Metastatic/recurrent Operable Gastrointestinal Stromal Tumors: Long-term Follow-up Results of Radiation Therapy Oncology Group 0132

G. Demetri, Q. Zhang, B. Eisenberg, 2012, Annals of Surgical Oncology.

A disappearing hepatic infusion pump

L. Henry, E. Sigurdson, J. C. Watson, 2005, Journal of Gastrointestinal Surgery.

Erratum to: Phase II Trial of Neoadjuvant/adjuvant Imatinib Mesylate for Advanced Primary and Metastatic/recurrent Operable Gastrointestinal Stromal Tumors: Long-term Follow-up Results of Radiation Therapy Oncology Group 0132

G. Demetri, Q. Zhang, B. Eisenberg, 2012, Annals of Surgical Oncology.

Poster Viewing PresentationRadiation Therapy in Gallbladder Cancer Treatment: The Fox Chase Cancer Center Experience

N. Meropol, J. C. Watson, J. Hoffman, 2007 .

Potential Prognostic Biomarkers of Pancreatic Cancer

Kelly A. Jones, Bhavinkumar B. Patel, K. Devarajan, 2014, Pancreas.